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ABSTRACT 
In Malaysia, the prevalence of hypertension has increased over the last 10 years. 
Considering the current trends in the prevalence of hypertension in Malaysia, it can be 
speculated that there will be further increases in the number of individuals with 
cardiovascular diseases, leading to increased healthcare related economic burden. 
Among the factors that contribute to the poor control of hypertension is poor compliance 
to treatment. On that note, herbs, which occupy an important place in society have been 
actively investigated for their pharmacological potential. In this regard, Ficus deltoidea 
plant has attracted attention of researches over the last few years. It has been 
scientifically proven to possess wide range of pharmacological activities, which include 
anti-diabetic, wound healing and anti-oxidant properties. The data on the effect of this 
plant on blood pressure are non-existent. Hence, this study investigated the blood 
pressure lowering effect of standardized aqueous-ethanolic extract of leaves of Ficus 
deltoidea Kunstleri (FDK extract) in spontaneously hypertensive rats (SHR). The 
possible mechanisms of its anti-hypertensive effect were also investigated. Firstly, the 
dose dependent effect of FDK extract was determined using 4 different doses (500, 800, 
1000, 1300 mg. Kg"1) that were administered orally for 4 weeks to SHR. Blood pressure 
was measured weekly using tail-cuff plethysmography. Besides blood pressure, body 
weight, urine output, food and water intake were also measured weekly. Subsequently, 
using the most effective dose, the effect of FDK extract on renin-angiotensin-
aldosterone system (RAAS), endothelial function and anti-oxidant status was examined. 
Urine was subjected to *H-NMR metabolomics and kidney tissue for gene expression 
studies. Systemic effects of FDK extract were studied by measuring liver and kidney 
functions as well as morphological features of kidney, aorta and heart. In the dose-
response study, 1000 mg.kg"1 dose had the largest blood pressure lowering effect, based 
on area under time versus response curve (AUC). When compared to the control group, 
FDK extract treated rats showed lower concentration of angiotensin I, angiotensin II, 
aldosterone and angiotensin converting enzyme (ACE) activity. In addition, FDK 
extract treated rats showed higher concentration of ACE2 and angiotensin 1-7 in the 
serum. RT-PCR showed significantly greater ACE2 gene expression in the kidney of 
FDK extract treated group compared to vehicle treated group. FDK extract treated rats 
had improved endothelial function as evidenced from the higher concentration of eNOS 
in this group compared to vehicle treated group. FDK extract treated rats also exhibited 
higher serum total anti-oxidant capacity (TAC) compared to that in the vehicle treated 
group. Additionally, urinary metabolomic studies revealed altered levels of amino 
acids, ketone bodies and substances involved in energy metabolism and oxidative stress 
in the FDK extract treated group, indicating its antioxidant properties in its anti-
hypertensive effect. The gene expression for FOX03a, SOD2 and catalase were 
significantly greater in the kidney of FDK extract treated group compared to vehicle 
treated group. No changes were observed in liver and kidney functions as well as in the 
morphology of kidney, heart and aorta of FDK extract treated group, indicating absence 
of significant adverse effects of FDK extract at the dose used. In conclusion, 
administration of 1000 mg.kg"1 of standardized aqueous-ethanolic extract of leaves of 
FDK reduces blood pressure in SHR by reducing RAAS activity and improving 
endothelial function and redox status. These effects of FDK extract seem to be 
associated with changes in several metabolic pathways, which include amino acid 
metabolism, synthesis and degradation of ketone bodies and energy metabolism. 
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CHAPTER ONE 
INTRODUCTION 
1.1 Research Background 
Hypertension is one of the commonest non-communicable diseases (NCD) 
worldwide. It is also the highest contributor to disability life-years (DALYs) for both 
males and females (Ministry of Health Malaysia, 2018) The prevalence of hypertension 
among adults aged 18 years and above in Malaysia was estimated at 35.3% in 2015 (Ab 
Majid et al, 2018). This has increased from the last few years whereby it was 30.3% 
based on the National Health and Morbidity Survey 2015 (Ministry of Health Malaysia, 
2015). It is noteworthy that non-communicable diseases accounted for 74% of all deaths 
in Malaysia in the year 2016, whereby 35% of deaths were attributed to cardiovascular 
diseases (World Health Organization, 2018). 
Primary or essential hypertension contributes to 95% of the cases of 
hypertension. Unlike secondary hypertension, the cause of essential hypertension is 
unknown. It is believed that essential hypertension involves complex 
pathophysiological mechanisms. Extensive research has been conducted in order to 
determine the precise pathophysiological mechanism of hypertension and then 
accordingly design therapeutic options for its treatment. Role of genetics in essential 
hypertension is considered complex as no single gene has been identified that 
contributes to the development of this disease. Polymorphism of several genes has been 
shown to correlate with the development of essential hypertension (Y. Chen et al, 2019; 
Jhuo et al, 2019). In the Malaysian population, close relationship was found between 
polymorphism of Ala589ser of WNK4 gene with increased blood pressure (Ghodsian 
et al., 2016). Though the role of genetics in human hypertension is increasingly 
recognized much however still needs to be identified. 
Sympathetic nervous system plays an integral part in the regulation of blood 
pressure. Alteration in the autonomic control was documented in the hypertensive rat 
model (Berg & Jensen, 2011). The altered autonomic control causes increased 
excitability of nucleaus tractus solitarii (NTS) of the hypothalamic paraventricular 
nucleus (HPN), probably involving a disruption in the balance between glutamatergic 
and GABAergic inputs (J. J. Zhou et al, 2019). Interestingly, exercise has been shown 
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